til rapporteret oftere end hos voksne patienter (2, 4% mod 1%) under behandling og under den 6- måneders opfølgning efter behandling.
Among children and adolescents treated with Viraferon in combination with ribavirin, suicidal ideation or attempts were reported more frequently compared to adult patients (2.4% vs 1%) during treatment and during the 6-month follow-up after treatment.